No abstract available
Keywords:
Covid-19; Lopinavir; Protease inhibitor; Sars-cov-2; Virology; pharmacology.
MeSH terms
-
Antiviral Agents* / therapeutic use
-
COVID-19*
-
Disease Outbreaks
-
Humans
-
Lopinavir / therapeutic use
-
Pneumonia* / drug therapy
-
Prospective Studies
-
Ritonavir / therapeutic use
-
SARS-CoV-2
-
Severe Acute Respiratory Syndrome*
-
Viral Load
Substances
-
Antiviral Agents
-
Lopinavir
-
Ritonavir